GlassScriptPhysician profile
David Bryn Kessler
NPI 1346327491
$1,542.21
in general payments reported to CMS, 2019-2025
7 companies · $203 in 2025
The $203 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $53.53 · 2022: $28.92 · 2023: $115 · 2024: $1,142 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,365 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,364.77 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,339.30 | 2021-2024 | Gallant, Amplatzer Amulet, Assurity |
| Sanofi-Aventis U.S. LLC | $94.99 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.75 | 2025 | |
| Axsome Therapeutics, INC. | $24.52 | 2025 | Sunosi |
| Astrazeneca Pharmaceuticals LP | $20.09 | 2025 | |
| Seqirus USA INC | $17.45 | 2025 | Fluad, Flucelvax |
| Merck Sharp & Dohme LLC | $16.11 | 2025 | Gardasil 9, Capvaxive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kessler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.